SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : T/FIF Portfolio -- Ignore unavailable to you. Want to Upgrade?

To: scaram(o)uche who wrote (93)9/7/1998 10:11:00 PM
From: mike head  Read Replies (1) | Respond to of 1073
 
Rick. while feeling in a mildly provocative mood, (thanks Henry}, on a scale of 1-10, how do you feel the results will turn out on your old 'favorites' (XOMA /Genentech) Hu1124 (anti-CD11 MAB)tests {PII, I guess} for Psoriasis? TIA. pax et bonum, mch



To: scaram(o)uche who wrote (93)9/8/1998 8:15:00 PM
From: Miljenko Zuanic  Respond to of 1073
 
This is terrible finance for XNVAY. Also, bt sector in UK is in worst position than in US. Good example is Chiro. I think (Jim probably also) that Chiro can be good substitution for XNVAY as at least 5 bagger in next two-three years.

RE: CRXA
Nice surprise from Corixa today. Patent and PI phase for MUC-1 vaccine:
biz.yahoo.com

Miljenko


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News